Novo Nordisk shares rise after Wegovy recommended by Britain's drug price regulator
">
Novo Nordisk shares rise after Wegovy recommended by Britain's drug price regulator
The new recommendation will significantly expand access to Wegovy on the England’s NHS.
This article was created based on information from various sources and rewritten for clarity and originality.
